Torchlight Innovations Inc. (DBA: RZOLV Technologies Inc.) Announces Listing Date After Completion of Qualifying TransactionOctober 23, 2025
Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO